Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
24
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Posner Christopher | President and CEO | 31 | $0 | $427.4K | 2025-02-28 |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | 39 | $0 | $566.7K | 2025-02-28 |
| Shiff Susan Ph.D. | Director | 9 | $0 | $0 | 2024-06-04 |
| von Moltke Lisa | Director | 5 | $0 | $0 | 2024-06-04 |
| Boudreau Helen M | Director | 3 | $0 | $0 | 2024-06-04 |
| Ives Jeffrey L. | Director | 58 | $0 | $785.5K | 2024-06-04 |
| VOGELBAUM MARTIN | Director | 27 | $4.43M | $320.3K | 2024-06-04 |
| Goncalves Joana | Chief Medical Officer | 42 | $0 | $942.1K | 2024-04-05 |
| Menzaghi Frederique Ph.D. | VP-Research & Development | 78 | $0 | $5.02M | 2024-02-01 |
| Maynard Ryan D | Chief Financial Officer | 4 | $0 | $2.9K | 2024-02-01 |
| BAINS HARRISON M JR | Director | 16 | $0 | $65.2K | 2023-06-01 |
| Makara Richard | VP, Head of Accting;Controller | 2 | $0 | $0 | 2022-06-15 |
| Reilly Thomas Charles | Chief Financial Officer | 8 | $0 | $51.4K | 2022-03-03 |
| CHALMERS DEREK T | President & CEO | 72 | $0 | $7.20M | 2021-09-07 |
| Mohindru Mani | CFO & Chief Strategy Officer | 20 | $0 | $2.05M | 2019-12-04 |
| Stauffer Joseph William | Chief Medical Officer | 8 | $37.2K | $230.3K | 2018-10-17 |
| Schoell Josef | Chief Financial Officer | 14 | $66.3K | $164.4K | 2017-07-26 |
| Slagel Dean | Director | 17 | $0 | $9.86M | 2017-06-29 |
| LESCHLY MARK | 10% Owner | 4 | $11.58M | $0 | 2017-03-31 |
| Lewis Michael E | Chief Scientific Advisor | 14 | $0 | $532.6K | 2017-03-08 |
| RHO Ventures VI LP | 10% Owner | 2 | $1.95M | $0 | 2016-03-17 |
| Medve Robert | Chief Medical Officer | 1 | $0 | $0 | 2014-06-17 |
| Moller Charles Ph.D. | Director | 5 | $0 | $0 | 2014-02-05 |
| HURWITZ EDWARD | Director, 10% Owner | 16 | $1.24M | $0 | 2014-02-05 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G. | S Sale | 2025-02-28 | 2025-03-04 | 163 | $4.76 | $776 | 7,190 | SEC↗ |
| Posner Christopher | PRESIDENT AND CEO | S Sale | 2025-02-28 | 2025-03-04 | 583 | $4.75 | $2.8K | 13,109 | SEC↗ |
| Posner Christopher | PRESIDENT AND CEO | S Sale | 2025-02-04 | 2025-02-06 | 372 | $4.72 | $1.8K | 13,692 | SEC↗ |
| Posner Christopher | PRESIDENT AND CEO | S Sale | 2024-11-04 | 2024-11-06 | 3,668 | $0.29 | $1.1K | 168,768 | SEC↗ |
| Posner Christopher | PRESIDENT AND CEO | S Sale | 2024-08-01 | 2024-08-02 | 4,149 | $0.35 | $1.5K | 172,436 | SEC↗ |
| VOGELBAUM MARTIN | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 390,000 | — | $0 | 390,000 | SEC↗ |
| Shiff Susan Ph.D. | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 195,000 | — | $0 | 195,000 | SEC↗ |
| Ives Jeffrey L. | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 195,000 | — | $0 | 195,000 | SEC↗ |
| von Moltke Lisa | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 195,000 | — | $0 | 195,000 | SEC↗ |
| Boudreau Helen M | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 195,000 | — | $0 | 195,000 | SEC↗ |
| VOGELBAUM MARTIN | Director | A Award | 2024-06-04 | 2024-06-06 | 301,295 | — | $0 | 411,007 | SEC↗ |
| Shiff Susan Ph.D. | Director | A Award | 2024-06-04 | 2024-06-06 | 150,647 | — | $0 | 202,085 | SEC↗ |
| Ives Jeffrey L. | Director | A Award | 2024-06-04 | 2024-06-06 | 150,647 | — | $0 | 198,485 | SEC↗ |
| von Moltke Lisa | Director | A Award | 2024-06-04 | 2024-06-06 | 150,647 | — | $0 | 183,009 | SEC↗ |
| Boudreau Helen M | Director | A Award | 2024-06-04 | 2024-06-06 | 150,647 | — | $0 | 150,647 | SEC↗ |
| Posner Christopher | PRESIDENT AND CEO | S Sale | 2024-05-02 | 2024-05-06 | 3,936 | $0.75 | $3.0K | 176,585 | SEC↗ |
| Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G. | S Sale | 2024-04-05 | 2024-04-09 | 2,753 | $0.83 | $2.3K | 88,247 | SEC↗ |
| Goncalves Joana | CHIEF MEDICAL OFFICER | S Sale | 2024-04-05 | 2024-04-09 | 2,753 | $0.83 | $2.3K | 53,365 | SEC↗ |
| Goncalves Joana | CHIEF MEDICAL OFFICER | S Sale | 2024-02-29 | 2024-03-04 | 3,293 | $0.89 | $2.9K | 56,118 | SEC↗ |
| Posner Christopher | PRESIDENT AND CEO | S Sale | 2024-02-29 | 2024-03-04 | 5,834 | $0.89 | $5.2K | 180,521 | SEC↗ |
| Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G. | S Sale | 2024-02-29 | 2024-03-04 | 3,293 | $0.89 | $2.9K | 91,000 | SEC↗ |
| Posner Christopher | PRESIDENT AND CEO | S Sale | 2024-02-08 | 2024-02-12 | 35,575 | $0.53 | $18.9K | 186,355 | SEC↗ |
| Posner Christopher | PRESIDENT AND CEO | S Sale | 2024-02-01 | 2024-02-05 | 4,981 | $0.55 | $2.7K | 221,930 | SEC↗ |
| Posner Christopher | PRESIDENT AND CEO | A Award | 2024-02-01 | 2024-02-05 | 62,500 | — | $0 | 226,911 | SEC↗ |
| Menzaghi Frederique Ph.D. | CHIEF SCIENTIFIC OFF,SVP-R&D | A Award | 2024-02-01 | 2024-02-05 | 13,500 | — | $0 | 167,247 | SEC↗ |
| Goncalves Joana | CHIEF MEDICAL OFFICER | A Award | 2024-02-01 | 2024-02-05 | 13,500 | — | $0 | 67,181 | SEC↗ |
| Maynard Ryan D | CHIEF FINANCIAL OFFICER | A Award | 2024-02-01 | 2024-02-05 | 13,500 | — | $0 | 13,500 | SEC↗ |
| Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G. | A Award | 2024-02-01 | 2024-02-05 | 13,500 | — | $0 | 102,063 | SEC↗ |
| Posner Christopher | President and CEO | S Sale | 2023-11-02 | 2023-11-03 | 3,796 | $1.22 | $4.6K | 164,411 | SEC↗ |
| Posner Christopher | President and CEO | S Sale | 2023-08-03 | 2023-08-04 | 4,307 | $3.07 | $13.2K | 168,207 | SEC↗ |
| Boudreau Helen M | Director | A Award deriv | 2023-08-02 | 2023-08-04 | 155,747 | — | $0 | 155,747 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2023-06-23 | 2023-06-27 | 2,723 | $3.51 | $9.6K | 53,681 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S Sale | 2023-06-23 | 2023-06-27 | 2,993 | $3.51 | $10.5K | 153,747 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | S Sale | 2023-06-23 | 2023-06-27 | 2,483 | $3.51 | $8.7K | 88,563 | SEC↗ |
| VOGELBAUM MARTIN | Director | A Award deriv | 2023-06-01 | 2023-06-05 | 89,923 | — | $0 | 89,923 | SEC↗ |
| BAINS HARRISON M JR | Director | A Award deriv | 2023-06-01 | 2023-06-05 | 44,961 | — | $0 | 44,961 | SEC↗ |
| Ives Jeffrey L. | Director | A Award deriv | 2023-06-01 | 2023-06-05 | 44,961 | — | $0 | 44,961 | SEC↗ |
| Shiff Susan Ph.D. | Director | A Award deriv | 2023-06-01 | 2023-06-05 | 44,961 | — | $0 | 44,961 | SEC↗ |
| von Moltke Lisa | Director | A Award deriv | 2023-06-01 | 2023-06-05 | 44,961 | — | $0 | 44,961 | SEC↗ |
| VOGELBAUM MARTIN | Director | A Award | 2023-06-01 | 2023-06-05 | 64,724 | — | $0 | 109,712 | SEC↗ |
| BAINS HARRISON M JR | Director | A Award | 2023-06-01 | 2023-06-05 | 32,362 | — | $0 | 57,438 | SEC↗ |
| Ives Jeffrey L. | Director | A Award | 2023-06-01 | 2023-06-05 | 32,362 | — | $0 | 47,838 | SEC↗ |
| Shiff Susan Ph.D. | Director | A Award | 2023-06-01 | 2023-06-05 | 32,362 | — | $0 | 51,438 | SEC↗ |
| von Moltke Lisa | Director | A Award | 2023-06-01 | 2023-06-05 | 32,362 | — | $0 | 32,362 | SEC↗ |
| Posner Christopher | President and CEO | S Sale | 2023-05-05 | 2023-05-09 | 3,869 | $4.40 | $17.0K | 172,514 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S Sale | 2023-04-04 | 2023-04-06 | 2,733 | $4.91 | $13.4K | 156,740 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2023-04-04 | 2023-04-06 | 2,481 | $4.91 | $12.2K | 56,404 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | S Sale | 2023-04-04 | 2023-04-06 | 2,481 | $4.91 | $12.2K | 91,046 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2023-03-03 | 2023-03-07 | 6,221 | $9.71 | $60.4K | 58,885 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | S Sale | 2023-03-03 | 2023-03-07 | 6,256 | $9.71 | $60.7K | 93,527 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S Sale | 2023-03-03 | 2023-03-07 | 6,802 | $9.71 | $66.0K | 159,473 | SEC↗ |
| Posner Christopher | President and CEO | S Sale | 2023-03-03 | 2023-03-07 | 5,987 | $9.71 | $58.1K | 176,383 | SEC↗ |
| Posner Christopher | President and CEO | A Award deriv | 2023-03-01 | 2023-03-03 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | A Award deriv | 2023-03-01 | 2023-03-03 | 81,000 | — | $0 | 81,000 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | A Award deriv | 2023-03-01 | 2023-03-03 | 81,000 | — | $0 | 81,000 | SEC↗ |
| Maynard Ryan D | Chief Financial Officer | A Award deriv | 2023-03-01 | 2023-03-03 | 81,000 | — | $0 | 81,000 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | A Award deriv | 2023-03-01 | 2023-03-03 | 81,000 | — | $0 | 81,000 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2023-02-16 | 2023-02-17 | 2,265 | $10.20 | $23.1K | 65,106 | SEC↗ |
| Goncalves Joana | CHIEF MEDICAL OFFICER | S Sale | 2023-02-08 | 2024-02-12 | 7,770 | $0.53 | $4.1K | 59,411 | SEC↗ |
| Maynard Ryan D | CHIEF FINANCIAL OFFICER | S Sale | 2023-02-08 | 2024-02-12 | 5,488 | $0.53 | $2.9K | 8,012 | SEC↗ |
| Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G. | S Sale | 2023-02-08 | 2024-02-12 | 7,770 | $0.53 | $4.1K | 94,293 | SEC↗ |
| Posner Christopher | President and CEO | S Sale | 2023-02-02 | 2023-02-03 | 4,191 | $11.80 | $49.5K | 182,370 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2023-01-17 | 2023-01-19 | 2,265 | $10.81 | $24.5K | 67,371 | SEC↗ |
| von Moltke Lisa | Director | A Award deriv | 2023-01-02 | 2023-01-19 | 45,841 | — | $0 | 45,841 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2022-12-29 | 2023-01-03 | 2,265 | $10.18 | $23.1K | 69,636 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | S Sale | 2022-12-21 | 2022-12-23 | 2,561 | $11.27 | $28.9K | 99,783 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2022-12-21 | 2022-12-23 | 2,992 | $11.27 | $33.7K | 71,901 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S Sale | 2022-12-21 | 2022-12-23 | 3,506 | $11.27 | $39.5K | 166,275 | SEC↗ |
| Posner Christopher | President and CEO | S Sale | 2022-11-16 | 2022-11-18 | 14,470 | $11.13 | $161.1K | 186,561 | SEC↗ |
| VOGELBAUM MARTIN | Director | S Sale | 2022-09-14 | 2022-09-16 | 10,800 | $10.28 | $111.0K | 44,988 | SEC↗ |
| Maynard Ryan D | Chief Financial Officer | A Award deriv | 2022-09-12 | 2022-09-14 | 225,000 | — | $0 | 225,000 | SEC↗ |
| BAINS HARRISON M JR | Director | S Sale | 2022-07-15 | 2022-07-19 | 7,200 | $9.05 | $65.2K | 25,076 | SEC↗ |
| Ives Jeffrey L. | Director | S Sale | 2022-07-15 | 2022-07-19 | 3,600 | $9.05 | $32.6K | 15,476 | SEC↗ |
| Makara Richard | VP, Head of Accting;Controll | A Award | 2022-06-15 | 2022-06-16 | 7,500 | — | $0 | 13,583 | SEC↗ |
| VOGELBAUM MARTIN | Director | A Award deriv | 2022-06-02 | 2022-06-06 | 33,993 | — | $0 | 33,993 | SEC↗ |
| BAINS HARRISON M JR | Director | A Award deriv | 2022-06-02 | 2022-06-06 | 16,996 | — | $0 | 16,996 | SEC↗ |
| Ives Jeffrey L. | Director | A Award deriv | 2022-06-02 | 2022-06-06 | 16,996 | — | $0 | 16,996 | SEC↗ |
| Shiff Susan Ph.D. | Director | A Award deriv | 2022-06-02 | 2022-06-06 | 16,996 | — | $0 | 16,996 | SEC↗ |
| VOGELBAUM MARTIN | Director | A Award | 2022-06-02 | 2022-06-06 | 23,752 | — | $0 | 43,912 | SEC↗ |
| VOGELBAUM MARTIN | Director | A Award | 2022-06-02 | 2022-06-06 | 11,876 | — | $0 | 55,788 | SEC↗ |
| BAINS HARRISON M JR | Director | A Award | 2022-06-02 | 2022-06-06 | 11,876 | — | $0 | 32,276 | SEC↗ |
| Ives Jeffrey L. | Director | A Award | 2022-06-02 | 2022-06-06 | 11,876 | — | $0 | 19,076 | SEC↗ |
| Shiff Susan Ph.D. | Director | A Award | 2022-06-02 | 2022-06-06 | 11,876 | — | $0 | 19,076 | SEC↗ |
| Posner Christopher | President and CEO | S Sale | 2022-04-04 | 2022-04-05 | 2,006 | $12.67 | $25.4K | 201,031 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S Sale | 2022-04-01 | 2022-04-05 | 1,784 | $11.91 | $21.2K | 169,781 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2022-04-01 | 2022-04-05 | 1,642 | $11.91 | $19.6K | 74,893 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | S Sale | 2022-04-01 | 2022-04-05 | 1,642 | $11.91 | $19.6K | 102,344 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | S Sale | 2022-03-03 | 2022-03-04 | 1,787 | $11.38 | $20.3K | 103,986 | SEC↗ |
| Reilly Thomas Charles | Chief Financial Officer | S Sale | 2022-03-03 | 2022-03-04 | 2,044 | $11.38 | $23.3K | 37,811 | SEC↗ |
| Reilly Thomas Charles | Chief Financial Officer | A Award | 2022-02-28 | 2022-03-01 | 5,333 | $10.29 | $54.9K | 39,855 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | A Award | 2022-02-28 | 2022-03-01 | 5,333 | — | $0 | 105,773 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | A Award deriv | 2022-02-25 | 2022-03-01 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | A Award deriv | 2022-02-25 | 2022-03-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Posner Christopher | President and CEO | A Award deriv | 2022-02-25 | 2022-03-01 | 121,000 | — | $0 | 121,000 | SEC↗ |
| Reilly Thomas Charles | Chief Financial Officer | A Award deriv | 2022-02-25 | 2022-03-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | A Award deriv | 2022-02-25 | 2022-03-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2022-02-25 | 2022-03-01 | 1,972 | $10.29 | $20.3K | 76,535 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | A Award | 2022-02-25 | 2022-03-01 | 20,000 | — | $0 | 78,507 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S Sale | 2022-02-25 | 2022-03-01 | 2,114 | $10.29 | $21.8K | 171,565 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | A Award | 2022-02-25 | 2022-03-01 | 20,000 | — | $0 | 173,679 | SEC↗ |
| Posner Christopher | President and CEO | A Award | 2022-02-25 | 2022-03-01 | 39,000 | — | $0 | 203,037 | SEC↗ |
| Reilly Thomas Charles | Chief Financial Officer | A Award | 2022-02-25 | 2022-03-01 | 20,000 | — | $0 | 34,522 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | S Sale | 2022-02-25 | 2022-03-01 | 1,972 | $10.29 | $20.3K | 100,440 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | A Award | 2022-02-25 | 2022-03-01 | 20,000 | — | $0 | 102,412 | SEC↗ |
| Reilly Thomas Charles | Chief Financial Officer | A Award | 2021-12-17 | 2021-12-21 | 11,170 | — | $0 | 14,522 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | A Award | 2021-12-17 | 2021-12-21 | 11,495 | — | $0 | 82,412 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | A Award | 2021-12-17 | 2021-12-21 | 12,607 | — | $0 | 58,507 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | A Award | 2021-12-17 | 2021-12-21 | 12,607 | — | $0 | 153,679 | SEC↗ |
| Ives Jeffrey L. | Director | S Sale | 2021-11-12 | 2021-11-16 | 8,180 | $16.04 | $131.2K | 7,200 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2021-11-01 | 2021-11-03 | 1,000 | $17.15 | $17.1K | 45,900 | SEC↗ |
| Posner Christopher | Director | A Award deriv | 2021-10-29 | 2021-11-03 | 566,000 | — | $0 | 566,000 | SEC↗ |
| Posner Christopher | Director | A Award | 2021-10-29 | 2021-11-03 | 5,941 | — | $0 | 22,037 | SEC↗ |
| Posner Christopher | Director | A Award | 2021-10-29 | 2021-11-03 | 142,000 | — | $0 | 164,037 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2021-10-27 | 2021-10-28 | 1,000 | $15.00 | $15.0K | 46,900 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2021-09-07 | 2021-09-09 | 20,000 | $15.47 | $309.4K | 991,405 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2021-08-30 | 2021-09-01 | 8,440 | $14.20 | $119.8K | 1,011,405 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2021-08-30 | 2021-09-01 | 2,110 | $14.20 | $30.0K | 47,900 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S Sale | 2021-08-30 | 2021-09-01 | 3,847 | $14.20 | $54.6K | 141,072 | SEC↗ |
| Reilly Thomas Charles | Chief Financial Officer | S Sale | 2021-08-30 | 2021-09-01 | 1,982 | $14.20 | $28.1K | 3,352 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | S Sale | 2021-08-30 | 2021-09-01 | 1,759 | $14.20 | $25.0K | 70,917 | SEC↗ |
| CHALMERS DEREK T | President & CEO | A Award | 2021-08-24 | 2021-08-26 | 17,334 | — | $0 | 1,019,845 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | A Award | 2021-08-24 | 2021-08-26 | 9,600 | — | $0 | 144,919 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | A Award | 2021-08-24 | 2021-08-26 | 6,400 | — | $0 | 50,010 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | A Award | 2021-08-24 | 2021-08-26 | 5,334 | — | $0 | 72,676 | SEC↗ |
| Reilly Thomas Charles | Chief Financial Officer | A Award | 2021-08-24 | 2021-08-26 | 5,334 | — | $0 | 5,334 | SEC↗ |
| Ives Jeffrey L. | Director | S Sale | 2021-06-07 | 2021-06-07 | 2,520 | $13.05 | $32.9K | 15,380 | SEC↗ |
| Posner Christopher | Director | S Sale | 2021-06-07 | 2021-06-07 | 2,304 | $13.04 | $30.0K | 16,096 | SEC↗ |
| VOGELBAUM MARTIN | Director | S Sale | 2021-06-07 | 2021-06-07 | 8,640 | $13.05 | $112.8K | 20,160 | SEC↗ |
| BAINS HARRISON M JR | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 10,800 | — | $0 | 10,800 | SEC↗ |
| Ives Jeffrey L. | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 10,800 | — | $0 | 10,800 | SEC↗ |
| Posner Christopher | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 10,800 | — | $0 | 10,800 | SEC↗ |
| Shiff Susan Ph.D. | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 10,800 | — | $0 | 10,800 | SEC↗ |
| VOGELBAUM MARTIN | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 21,600 | — | $0 | 21,600 | SEC↗ |
| BAINS HARRISON M JR | Director | A Award | 2021-06-03 | 2021-06-07 | 7,200 | — | $0 | 20,400 | SEC↗ |
| Ives Jeffrey L. | Director | A Award | 2021-06-03 | 2021-06-07 | 7,200 | — | $0 | 17,900 | SEC↗ |
| Posner Christopher | Director | A Award | 2021-06-03 | 2021-06-07 | 7,200 | — | $0 | 18,400 | SEC↗ |
| Shiff Susan Ph.D. | Director | A Award | 2021-06-03 | 2021-06-07 | 7,200 | — | $0 | 7,200 | SEC↗ |
| VOGELBAUM MARTIN | Director | A Award | 2021-06-03 | 2021-06-07 | 14,400 | — | $0 | 28,800 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2021-04-21 | 2021-04-23 | 3,000 | $27.63 | $82.9K | 43,610 | SEC↗ |
| CHALMERS DEREK T | President & CEO | A Award deriv | 2021-03-30 | 2021-04-01 | 103,000 | — | $0 | 103,000 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | A Award deriv | 2021-03-30 | 2021-04-01 | 32,000 | — | $0 | 32,000 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | A Award deriv | 2021-03-30 | 2021-04-01 | 32,000 | — | $0 | 32,000 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | A Award deriv | 2021-03-30 | 2021-04-01 | 32,000 | — | $0 | 32,000 | SEC↗ |
| CHALMERS DEREK T | President & CEO | A Award | 2021-03-30 | 2021-04-01 | 52,000 | — | $0 | 1,002,511 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | A Award | 2021-03-30 | 2021-04-01 | 16,000 | — | $0 | 46,610 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | A Award | 2021-03-30 | 2021-04-01 | 16,000 | — | $0 | 135,319 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | A Award | 2021-03-30 | 2021-04-01 | 16,000 | — | $0 | 67,342 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2021-03-22 | 2021-03-24 | 3,000 | $19.65 | $58.9K | 30,610 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2021-03-05 | 2021-03-08 | 3,103 | $17.98 | $55.8K | 950,511 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2021-03-05 | 2021-03-08 | 3,093 | $17.98 | $55.6K | 33,610 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | S Sale | 2021-03-05 | 2021-03-08 | 3,090 | $17.98 | $55.6K | 51,342 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S Sale | 2021-03-05 | 2021-03-08 | 3,358 | $17.98 | $60.4K | 119,319 | SEC↗ |
| CHALMERS DEREK T | President & CEO | A Award | 2021-03-04 | 2021-03-08 | 10,000 | — | $0 | 953,614 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | A Award | 2021-03-04 | 2021-03-08 | 10,000 | — | $0 | 36,703 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | A Award | 2021-03-04 | 2021-03-08 | 10,000 | — | $0 | 54,432 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | A Award | 2021-03-04 | 2021-03-08 | 10,000 | — | $0 | 122,677 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2021-02-25 | 2021-02-25 | 11,729 | $19.33 | $226.7K | 943,614 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2021-02-25 | 2021-02-25 | 3,372 | $19.33 | $65.2K | 26,703 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S Sale | 2021-02-25 | 2021-02-25 | 5,003 | $19.33 | $96.7K | 112,677 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | S Sale | 2021-02-25 | 2021-02-25 | 4,004 | $19.33 | $77.4K | 44,432 | SEC↗ |
| CHALMERS DEREK T | President & CEO | A Award | 2021-02-23 | 2021-02-25 | 18,750 | — | $0 | 955,343 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | A Award | 2021-02-23 | 2021-02-25 | 4,000 | — | $0 | 30,075 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | A Award | 2021-02-23 | 2021-02-25 | 8,000 | — | $0 | 117,680 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | A Award | 2021-02-23 | 2021-02-25 | 6,000 | — | $0 | 48,436 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2021-02-22 | 2021-02-24 | 2,000 | $19.73 | $39.5K | 26,075 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2021-01-21 | 2021-01-25 | 2,000 | $20.12 | $40.2K | 28,075 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2020-12-30 | 2020-12-30 | 6,078 | $15.30 | $93.0K | 936,593 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2020-12-30 | 2020-12-30 | 1,298 | $15.30 | $19.9K | 30,075 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S Sale | 2020-12-30 | 2020-12-30 | 2,812 | $15.30 | $43.0K | 109,680 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | S Sale | 2020-12-30 | 2020-12-30 | 1,946 | $15.30 | $29.8K | 42,436 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2020-12-28 | 2020-12-29 | 5,000 | $16.00 | $80.0K | 942,671 | SEC↗ |
| CHALMERS DEREK T | President & CEO | A Award | 2020-12-23 | 2020-12-29 | 18,750 | — | $0 | 947,671 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | A Award | 2020-12-23 | 2020-12-29 | 6,000 | — | $0 | 44,382 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | A Award | 2020-12-23 | 2020-12-29 | 4,000 | — | $0 | 31,373 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | A Award | 2020-12-23 | 2020-12-29 | 8,000 | — | $0 | 112,492 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2020-12-21 | 2020-12-23 | 2,000 | $15.00 | $30.0K | 27,373 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2020-12-16 | 2020-12-18 | 5,000 | $14.95 | $74.8K | 928,921 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2020-12-10 | 2020-12-11 | 7,500 | $15.29 | $114.7K | 933,921 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2020-11-23 | 2020-11-25 | 2,000 | $15.31 | $30.6K | 29,373 | SEC↗ |
| Ives Jeffrey L. | Director | A Award | 2020-11-19 | 2020-11-23 | 2,500 | $15.75 | $39.4K | 10,700 | SEC↗ |
| Posner Christopher | Director | S Sale | 2020-11-19 | 2020-11-23 | 2,000 | $15.82 | $31.6K | 11,200 | SEC↗ |
| Ives Jeffrey L. | Director | S Sale | 2020-11-19 | 2020-11-24 | 2,500 | $15.75 | $39.4K | 10,700 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2020-11-17 | 2020-11-19 | 11,799 | $16.00 | $188.8K | 941,421 | SEC↗ |
| VOGELBAUM MARTIN | Director | S Sale | 2020-11-17 | 2020-11-19 | 6,000 | $16.09 | $96.5K | 14,400 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2020-11-10 | 2020-11-13 | 2,000 | $15.00 | $30.0K | 31,373 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2020-10-20 | 2020-10-22 | 2,000 | $15.00 | $30.0K | 33,373 | SEC↗ |
| Reilly Thomas Charles | Chief Financial Officer | A Award deriv | 2020-10-01 | 2020-10-07 | 175,000 | — | $0 | 175,000 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2020-09-03 | 2020-09-08 | 3,201 | $16.00 | $51.2K | 953,220 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2020-08-03 | 2020-08-05 | 5,000 | $16.42 | $82.1K | 956,421 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2020-07-01 | 2020-07-02 | 5,000 | $17.11 | $85.5K | 961,421 | SEC↗ |
| Shiff Susan Ph.D. | Director | A Award deriv | 2020-06-26 | 2020-06-30 | 38,000 | — | $0 | 38,000 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | S Sale | 2020-06-12 | 2020-06-12 | 10,627 | $15.20 | $161.5K | 35,373 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | A Award | 2020-06-10 | 2020-06-12 | 30,000 | — | $0 | 46,000 | SEC↗ |
| Posner Christopher | Director | A Award deriv | 2020-06-04 | 2020-06-08 | 10,800 | — | $0 | 10,800 | SEC↗ |
| Ives Jeffrey L. | Director | A Award deriv | 2020-06-04 | 2020-06-08 | 10,800 | — | $0 | 10,800 | SEC↗ |
| BAINS HARRISON M JR | Director | A Award deriv | 2020-06-04 | 2020-06-08 | 10,800 | — | $0 | 10,800 | SEC↗ |
| VOGELBAUM MARTIN | Director | A Award deriv | 2020-06-04 | 2020-06-08 | 21,600 | — | $0 | 21,600 | SEC↗ |
| Posner Christopher | Director | A Award | 2020-06-04 | 2020-06-08 | 7,200 | — | $0 | 13,200 | SEC↗ |
| Ives Jeffrey L. | Director | A Award | 2020-06-04 | 2020-06-08 | 7,200 | — | $0 | 13,200 | SEC↗ |
| BAINS HARRISON M JR | Director | A Award | 2020-06-04 | 2020-06-08 | 7,200 | — | $0 | 13,200 | SEC↗ |
| VOGELBAUM MARTIN | Director | A Award | 2020-06-04 | 2020-06-08 | 14,400 | — | $0 | 20,400 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2020-06-03 | 2020-06-03 | 4,300 | $16.01 | $68.8K | 966,421 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise deriv | 2020-06-01 | 2020-06-03 | 1,000 | — | $0 | 0 | SEC↗ |
| Ives Jeffrey L. | Director | S Sale | 2020-06-01 | 2020-06-03 | 1,000 | $16.00 | $16.0K | 6,000 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise | 2020-06-01 | 2020-06-03 | 1,000 | $9.94 | $9.9K | 7,000 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2020-06-01 | 2020-06-03 | 700 | $16.00 | $11.2K | 970,721 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2020-05-22 | 2020-05-22 | 371 | $16.00 | $5.9K | 971,421 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2020-05-21 | 2020-05-22 | 3,500 | $16.00 | $56.0K | 971,792 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2020-05-20 | 2020-05-22 | 1,200 | $16.00 | $19.2K | 975,292 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise deriv | 2020-05-12 | 2020-05-14 | 2,500 | — | $0 | 1,000 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise | 2020-05-12 | 2020-05-14 | 2,500 | $9.94 | $24.9K | 8,500 | SEC↗ |
| Ives Jeffrey L. | Director | S Sale | 2020-05-12 | 2020-05-14 | 2,500 | $16.00 | $40.0K | 6,000 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2020-05-12 | 2020-05-14 | 4,929 | $16.00 | $78.9K | 976,492 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise deriv | 2020-04-21 | 2020-04-21 | 2,500 | — | $0 | 3,500 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2020-04-21 | 2020-04-21 | 6,348 | $15.56 | $98.8K | 981,421 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S Sale | 2020-04-21 | 2020-04-21 | 12,894 | $15.58 | $200.9K | 104,492 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | S Sale | 2020-04-21 | 2020-04-21 | 2,721 | $15.56 | $42.3K | 38,382 | SEC↗ |
| Ives Jeffrey L. | Director | S Sale | 2020-04-21 | 2020-04-21 | 2,500 | $16.00 | $40.0K | 6,000 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise | 2020-04-21 | 2020-04-21 | 2,500 | $9.94 | $24.9K | 8,500 | SEC↗ |
| CHALMERS DEREK T | President & CEO | A Award | 2020-04-17 | 2020-04-21 | 20,000 | — | $0 | 987,769 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | A Award | 2020-04-17 | 2020-04-21 | 37,500 | — | $0 | 117,386 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | A Award | 2020-04-17 | 2020-04-21 | 8,334 | — | $0 | 41,103 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise deriv | 2020-03-04 | 2020-03-06 | 2,500 | — | $0 | 6,000 | SEC↗ |
| Ives Jeffrey L. | Director | S Sale | 2020-03-04 | 2020-03-06 | 2,500 | $16.00 | $40.0K | 6,000 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise | 2020-03-04 | 2020-03-06 | 2,500 | $9.94 | $24.9K | 8,500 | SEC↗ |
| CHALMERS DEREK T | President & CEO | A Award deriv | 2020-02-24 | 2020-02-26 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | A Award deriv | 2020-02-24 | 2020-02-26 | 32,000 | — | $0 | 32,000 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | A Award deriv | 2020-02-24 | 2020-02-26 | 32,000 | — | $0 | 32,000 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | A Award deriv | 2020-02-24 | 2020-02-26 | 32,000 | — | $0 | 32,000 | SEC↗ |
| Makara Richard | VP, Head of Accting;Controll | A Award deriv | 2020-02-24 | 2020-02-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CHALMERS DEREK T | President & CEO | A Award | 2020-02-24 | 2020-02-26 | 50,000 | — | $0 | 967,769 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | A Award | 2020-02-24 | 2020-02-26 | 16,000 | — | $0 | 79,886 | SEC↗ |
| Goncalves Joana | Chief Medical Officer | A Award | 2020-02-24 | 2020-02-26 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | A Award | 2020-02-24 | 2020-02-26 | 16,000 | — | $0 | 32,769 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise deriv | 2020-02-03 | 2020-02-05 | 2,500 | — | $0 | 8,500 | SEC↗ |
| Ives Jeffrey L. | Director | S Sale | 2020-02-03 | 2020-02-05 | 2,500 | $16.23 | $40.6K | 6,000 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise | 2020-02-03 | 2020-02-05 | 2,500 | $9.94 | $24.9K | 8,500 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise deriv | 2020-01-02 | 2020-01-06 | 2,500 | — | $0 | 11,000 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2020-01-02 | 2020-01-06 | 10,000 | $16.05 | $160.5K | 917,769 | SEC↗ |
| Ives Jeffrey L. | Director | S Sale | 2020-01-02 | 2020-01-06 | 2,500 | $16.13 | $40.3K | 6,000 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise | 2020-01-02 | 2020-01-06 | 2,500 | $9.94 | $24.9K | 8,500 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2019-12-04 | 2019-12-04 | 10,699 | $17.05 | $182.4K | 927,769 | SEC↗ |
| Mohindru Mani | CFO & Chief Strategy Officer | S Sale | 2019-12-04 | 2019-12-04 | 4,755 | $17.05 | $81.1K | 17,441 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | S Sale | 2019-12-04 | 2019-12-04 | 3,980 | $17.05 | $67.9K | 16,769 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise deriv | 2019-12-02 | 2019-12-04 | 2,500 | — | $0 | 0 | SEC↗ |
| CHALMERS DEREK T | President & CEO | A Award | 2019-12-02 | 2019-12-04 | 20,000 | — | $0 | 938,468 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2019-12-02 | 2019-12-04 | 10,000 | $25.79 | $257.9K | 918,468 | SEC↗ |
| Ives Jeffrey L. | Director | S Sale | 2019-12-02 | 2019-12-04 | 2,500 | $25.83 | $64.6K | 6,000 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise | 2019-12-02 | 2019-12-04 | 2,500 | $5.32 | $13.3K | 8,500 | SEC↗ |
| Mohindru Mani | CFO & Chief Strategy Officer | A Award | 2019-12-02 | 2019-12-04 | 8,333 | — | $0 | 22,196 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | A Award | 2019-12-02 | 2019-12-04 | 8,333 | — | $0 | 20,749 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise deriv | 2019-11-01 | 2019-11-05 | 2,500 | — | $0 | 2,500 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2019-11-01 | 2019-11-05 | 5,000 | $20.79 | $104.0K | 928,468 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise | 2019-11-01 | 2019-11-05 | 2,500 | $5.32 | $13.3K | 8,500 | SEC↗ |
| Ives Jeffrey L. | Director | S Sale | 2019-11-01 | 2019-11-05 | 2,500 | $20.68 | $51.7K | 6,000 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S Sale | 2019-10-25 | 2019-10-29 | 4,000 | $19.91 | $79.6K | 63,886 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S Sale | 2019-10-18 | 2019-10-22 | 4,000 | $19.33 | $77.3K | 67,886 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S Sale | 2019-10-11 | 2019-10-16 | 4,000 | $18.70 | $74.8K | 71,886 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S Sale | 2019-10-04 | 2019-10-08 | 4,000 | $19.19 | $76.8K | 75,886 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise deriv | 2019-10-01 | 2019-10-03 | 2,500 | — | $0 | 5,000 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2019-10-01 | 2019-10-03 | 10,000 | $18.28 | $182.8K | 933,468 | SEC↗ |
| Ives Jeffrey L. | Director | S Sale | 2019-10-01 | 2019-10-03 | 2,500 | $18.21 | $45.5K | 6,000 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise | 2019-10-01 | 2019-10-03 | 2,500 | $5.32 | $13.3K | 8,500 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise deriv | 2019-09-03 | 2019-09-05 | 2,500 | — | $0 | 7,500 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2019-09-03 | 2019-09-05 | 5,000 | $23.26 | $116.3K | 943,468 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise | 2019-09-03 | 2019-09-05 | 2,500 | $5.32 | $13.3K | 8,500 | SEC↗ |
| Ives Jeffrey L. | Director | S Sale | 2019-09-03 | 2019-09-05 | 2,500 | $23.31 | $58.3K | 6,000 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S Sale | 2019-09-03 | 2019-09-05 | 20,000 | $22.92 | $458.4K | 79,886 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise deriv | 2019-08-01 | 2019-08-05 | 2,500 | — | $0 | 10,000 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2019-08-01 | 2019-08-05 | 10,000 | $23.27 | $232.7K | 948,468 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise | 2019-08-01 | 2019-08-05 | 2,500 | $5.32 | $13.3K | 8,500 | SEC↗ |
| Ives Jeffrey L. | Director | S Sale | 2019-08-01 | 2019-08-05 | 2,500 | $23.24 | $58.1K | 6,000 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S Sale | 2019-08-01 | 2019-08-05 | 20,000 | $23.24 | $464.8K | 99,886 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S Sale | 2019-07-17 | 2019-07-19 | 8,996 | $27.50 | $247.4K | 119,886 | SEC↗ |
| Mohindru Mani | CFO & Chief Strategy Officer | M Exercise deriv | 2019-07-15 | 2019-07-17 | 37,431 | — | $0 | 299,444 | SEC↗ |
| Mohindru Mani | CFO & Chief Strategy Officer | M Exercise | 2019-07-15 | 2019-07-17 | 37,431 | $14.06 | $526.3K | 51,294 | SEC↗ |
| Mohindru Mani | CFO & Chief Strategy Officer | S Sale | 2019-07-15 | 2019-07-17 | 37,431 | $25.00 | $935.8K | 13,863 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise deriv | 2019-07-01 | 2019-07-03 | 2,500 | — | $0 | 12,500 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S Sale | 2019-07-01 | 2019-07-03 | 20,000 | $21.90 | $438.0K | 128,882 | SEC↗ |
| Ives Jeffrey L. | Director | S Sale | 2019-07-01 | 2019-07-03 | 2,500 | $21.75 | $54.4K | 6,000 | SEC↗ |
| Ives Jeffrey L. | Director | M Exercise | 2019-07-01 | 2019-07-03 | 2,500 | $5.32 | $13.3K | 8,500 | SEC↗ |
| VOGELBAUM MARTIN | Director | A Award | 2019-06-04 | 2019-07-01 | 6,000 | — | $0 | 6,000 | SEC↗ |
| BAINS HARRISON M JR | Director | A Award deriv | 2019-06-04 | 2019-06-06 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Ives Jeffrey L. | Director | A Award deriv | 2019-06-04 | 2019-06-06 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Posner Christopher | Director | A Award deriv | 2019-06-04 | 2019-06-06 | 9,000 | — | $0 | 9,000 | SEC↗ |
| VOGELBAUM MARTIN | Director | A Award deriv | 2019-06-04 | 2019-06-06 | 9,000 | — | $0 | 9,000 | SEC↗ |
| BAINS HARRISON M JR | Director | A Award | 2019-06-04 | 2019-06-06 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Ives Jeffrey L. | Director | A Award | 2019-06-04 | 2019-06-06 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Posner Christopher | Director | A Award | 2019-06-04 | 2019-06-06 | 6,000 | — | $0 | 6,000 | SEC↗ |
| VOGELBAUM MARTIN | Director | A Award | 2019-06-04 | 2019-06-06 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S Sale | 2019-05-29 | 2019-05-30 | 11,397 | $21.19 | $241.5K | 148,882 | SEC↗ |
| Mohindru Mani | CFO & Chief Strategy Officer | S Sale | 2019-05-29 | 2019-05-30 | 2,496 | $21.39 | $53.4K | 13,863 | SEC↗ |
| CHALMERS DEREK T | President & CEO | S Sale | 2019-05-29 | 2019-05-30 | 5,528 | $21.42 | $118.4K | 958,468 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | S Sale | 2019-05-29 | 2019-05-30 | 2,303 | $21.38 | $49.2K | 12,416 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | A Award | 2019-05-28 | 2019-05-30 | 37,500 | — | $0 | 160,279 | SEC↗ |
| Mohindru Mani | CFO & Chief Strategy Officer | A Award | 2019-05-28 | 2019-05-30 | 8,333 | — | $0 | 16,359 | SEC↗ |
| CHALMERS DEREK T | President & CEO | A Award | 2019-05-28 | 2019-05-30 | 20,000 | — | $0 | 963,996 | SEC↗ |
| Terrillion Scott | Sec'y; Chief Compliance & G. | A Award | 2019-05-28 | 2019-05-30 | 8,333 | — | $0 | 14,719 | SEC↗ |
| Mohindru Mani | CFO & Chief Strategy Officer | M Exercise deriv | 2019-03-13 | 2019-03-15 | 16,041 | — | $0 | 336,875 | SEC↗ |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S Sale | 2019-03-13 | 2019-03-14 | 16,803 | $18.87 | $317.1K | 122,779 | SEC↗ |